X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4376) 4376
Newspaper Article (724) 724
Newsletter (274) 274
Publication (229) 229
Book Review (123) 123
Magazine Article (111) 111
Book Chapter (88) 88
Trade Publication Article (71) 71
Book / eBook (15) 15
Transcript (14) 14
Dissertation (7) 7
Conference Proceeding (5) 5
Reference (3) 3
Data Set (1) 1
Report (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
insulin (3648) 3648
humans (3078) 3078
diabetes (2594) 2594
index medicus (2242) 2242
diabetes mellitus, type 2 - drug therapy (1732) 1732
endocrinology & metabolism (1641) 1641
male (1622) 1622
hypoglycemic agents - administration & dosage (1603) 1603
female (1599) 1599
type 2 diabetes (1542) 1542
hypoglycemic agents - therapeutic use (1334) 1334
hypoglycemia (1298) 1298
insulin glargine (1283) 1283
insulin - administration & dosage (1279) 1279
middle aged (1230) 1230
glucose (1069) 1069
insulin - therapeutic use (1022) 1022
care and treatment (936) 936
glycemic control (929) 929
insulin - analogs & derivatives (900) 900
adult (890) 890
aged (872) 872
diabetes therapy (817) 817
diabetes mellitus, type 1 - drug therapy (778) 778
research (735) 735
dosage and administration (725) 725
blood glucose - metabolism (724) 724
hyperglycemia (724) 724
diabetes mellitus, type 2 - blood (721) 721
treatment outcome (705) 705
therapy (704) 704
hypoglycemic agents - adverse effects (693) 693
glargine (684) 684
drug therapy (673) 673
diabetes mellitus (618) 618
insulin, long-acting (609) 609
blood glucose - drug effects (600) 600
drug administration schedule (595) 595
mellitus (533) 533
nph insulin (531) 531
type 1 diabetes (529) 529
medicine, general & internal (525) 525
glycated hemoglobin a - metabolism (516) 516
basal insulin (502) 502
clinical trials (496) 496
health aspects (483) 483
pharmaceutical industry (471) 471
hypoglycemia - chemically induced (442) 442
risk factors (438) 438
metformin (430) 430
patients (425) 425
drug therapy, combination (422) 422
insulin - adverse effects (420) 420
pharmacology & pharmacy (403) 403
insulin, long-acting - administration & dosage (402) 402
management (388) 388
glycated hemoglobin a - analysis (387) 387
analysis (379) 379
blood sugar (374) 374
internal medicine (365) 365
blood glucose - analysis (361) 361
studies (360) 360
insulin resistance (352) 352
adolescent (348) 348
diabetes mellitus, type 1 - blood (332) 332
animals (326) 326
open-label (325) 325
efficacy (311) 311
fda approval (300) 300
diabetes mellitus - drug therapy (297) 297
review (296) 296
usage (284) 284
injections, subcutaneous (282) 282
safety (282) 282
insulin detemir (270) 270
dose-response relationship, drug (266) 266
risk (266) 266
hypoglycemia - prevention & control (262) 262
type 2 diabetes mellitus (258) 258
diabetics (254) 254
insulin, long-acting - therapeutic use (254) 254
glycosylated hemoglobin (252) 252
dextrose (250) 250
medicine (246) 246
complications and side effects (238) 238
endocrinology (238) 238
hypoglycemic agents (237) 237
medicine, research & experimental (237) 237
trial (236) 236
body mass index (235) 235
to-target trial (235) 235
mortality (233) 233
drug dosages (231) 231
complications (230) 230
medical research (230) 230
retrospective studies (230) 230
medicine & public health (227) 227
child (226) 226
double-blind (226) 226
hypoglycemic agents - pharmacology (223) 223
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (9) 9
Collection Dvlpm't (Acquisitions) - Vendor file (6) 6
Scarborough Hospital - Birchmount (2) 2
Baycrest Hospital - Stacks (1) 1
Gerstein Science - Circulation Desk (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Toronto East General Hospital - Stacks (1) 1
Trillium Health Centre - Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
West Park Healthcare Centre - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5517) 5517
German (59) 59
French (21) 21
Spanish (18) 18
Hungarian (9) 9
Japanese (9) 9
Portuguese (8) 8
Chinese (6) 6
Czech (5) 5
Italian (3) 3
Korean (3) 3
Swedish (3) 3
Turkish (3) 3
Arabic (2) 2
Polish (2) 2
Serbian (2) 2
Danish (1) 1
Estonian (1) 1
Finnish (1) 1
Lithuanian (1) 1
Norwegian (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Diabetes, Obesity and Metabolism, ISSN 1462-8902, 04/2015, Volume 17, Issue 4, pp. 386 - 394
Journal Article
Journal Article
Journal Article
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 12/2017, Volume 19, Issue 12, pp. 1798 - 1804
To determine whether baseline characteristics had an impact on clinical outcomes in the LixiLan‐O trial (N = 1170), we compared the efficacy and safety of... 
type 2 diabetes mellitus | GLP | glycaemic control | insulin therapy | GLP-1 | EFFICACY | SAFETY | ONCE-DAILY LIXISENATIDE | RANDOMIZED-TRIAL | 24-WEEK | PLUS LIXISENATIDE | ENDOCRINOLOGY & METABOLISM | TYPE-2 | GETGOAL-L | Glycated Hemoglobin A - analysis | Humans | Middle Aged | Diabetes Mellitus, Type 2 - metabolism | Peptides - administration & dosage | Hypoglycemia - prevention & control | Insulin Glargine - administration & dosage | Drug Therapy, Combination - adverse effects | Glucagon-Like Peptide-1 Receptor - metabolism | Postprandial Period | Weight Gain - drug effects | Hypoglycemia - chemically induced | Diabetes Mellitus, Type 2 - complications | Drug Resistance | Body Mass Index | Hyperglycemia - prevention & control | Insulin Glargine - adverse effects | Obesity - complications | Insulin Glargine - therapeutic use | Disease Progression | Diabetes Mellitus, Type 2 - physiopathology | Diabetes Mellitus, Type 2 - drug therapy | Drug Combinations | Glucagon-Like Peptide-1 Receptor - agonists | Peptides - adverse effects | Peptides - therapeutic use | Type 2 diabetes | Glycosylated hemoglobin | Body mass index | Insulin | Patient outcomes | Subpopulations | Diabetes mellitus | Hemoglobin | Diabetes | Hypoglycemia | Diabetes mellitus (non-insulin dependent) | Clinical outcomes | Brief Report | Brief Reports | GLP‐1
Journal Article
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 12/2015, Volume 17, Issue 12, pp. 1142 - 1149
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 04/2016, Volume 18, Issue 4, pp. 366 - 374
Aims: To compare the efficacy and safety of insulin glargine 300 U/ml (Gla-300) with glargine 100 U/ml (Gla-100) in Japanese people with type 2 diabetes using... 
phase | basal insulin | study | type 2 diabetes | randomized trial | III | glycaemic control | insulin analogues | Phase III study | Type 2 diabetes | Insulin analogues | Randomized trial | Basal insulin | Glycaemic control | GLYCEMIC CONTROL | phase III study | ENDOCRINOLOGY & METABOLISM | MELLITUS | PROVIDES | UNITS/ML | Glycated Hemoglobin A - analysis | Japan - epidemiology | Hypoglycemia - epidemiology | Follow-Up Studies | Drug Resistance, Multiple | Humans | Middle Aged | Insulin Detemir - therapeutic use | Male | Risk | Delayed-Action Preparations - administration & dosage | Dose-Response Relationship, Drug | Hypoglycemia - prevention & control | Insulin Glargine - administration & dosage | Drug Therapy, Combination - adverse effects | Hypoglycemic Agents - administration & dosage | Insulin Detemir - adverse effects | Female | Hypoglycemia - chemically induced | Hypoglycemic Agents - therapeutic use | Hyperglycemia - prevention & control | Insulin Glargine - adverse effects | Administration, Oral | Insulin Glargine - therapeutic use | Diabetes Mellitus, Type 2 - blood | Delayed-Action Preparations - adverse effects | Delayed-Action Preparations - therapeutic use | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Hemoglobin | Glucose | Insulin | Dextrose | Diabetes therapy | Confidence intervals | Diabetes | Hypoglycemia | Body mass index | Diabetes mellitus | Diabetes mellitus (non-insulin dependent) | Original
Journal Article
Journal Article
Journal Article
Journal Article